Weighted Average Number of Shares Outstanding, Diluted of THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. from 31 Mar 2018 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Mar 2018 to 30 Sep 2024.
  • THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2024 was 4,913,103,351, a 49% increase year-over-year.
  • THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 3,168,900,801, a 25% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 4,913,103,351 +1,626,193,956 +49% 01 Jul 2024 30 Sep 2024 10-Q 20 Nov 2024 2024 Q3
Q2 2024 4,511,799,474 +1,535,672,391 +52% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 3,953,546,003 +1,261,489,259 +47% 01 Jan 2024 31 Mar 2024 10-Q 30 May 2024 2024 Q1
Q4 2023 3,168,900,801 01 Oct 2023 31 Dec 2023 10-K 17 Apr 2024 2023 FY
Q3 2023 3,286,909,395 +721,246,347 +28% 01 Jul 2023 30 Sep 2023 10-Q 20 Nov 2024 2024 Q3
Q2 2023 2,976,127,083 +434,697,879 +17% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024 2024 Q2
Q1 2023 2,692,056,744 01 Jan 2023 31 Mar 2023 10-Q 30 May 2024 2024 Q1
Q3 2022 2,565,663,048 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 2,541,429,204 01 Apr 2022 30 Jun 2022 10-Q 21 Aug 2023 2023 Q2
Q1 2021 2,240,039,437 +344,755,755 +18% 01 Jan 2021 31 Mar 2021 10-Q/A 21 May 2021 2021 Q1
Q1 2020 1,895,283,682 0 0% 01 Jan 2020 31 Mar 2020 10-Q/A 09 Jul 2020 2020 Q1
Q1 2019 1,895,283,682 +804,210,500 +74% 01 Jan 2019 31 Mar 2019 10-Q/A 21 May 2021 2021 Q1
Q1 2018 1,091,073,182 01 Jan 2018 31 Mar 2018 10-Q/A 09 Jul 2020 2020 Q1

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 3,168,900,801 +640,837,843 +25% 01 Jan 2023 31 Dec 2023 10-K 17 Apr 2024 2023 FY
2022 2,528,062,958 01 Jan 2022 31 Dec 2022 10-K 17 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.